SCHEMBL10698481

SCHEMBL10698481

CC(C)(C)n1cc(C(=O)O)c(=O)c2cc(F)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
LMNA P02545 4/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP1A2 P05177 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 4/20 0.42
TSHR P16473 2/20 0.42
RAB9A P51151 1/20 0.42
DRD3 P35462 1/20 0.40
CYP2D6 P10635 1/20 0.40
APEX1 P27695 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HTT P42858 2/20 0.39
THRB P10828 1/20 0.39
BRD4 O60885 1/20 0.39
CYP2J2 P51589 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150175 0.83 KDM4E (0.42) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL7845387 0.83 ALDH1A1 (0.46) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL3812812 0.78 ALDH1A1 (0.43) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL27976888 0.78 ALDH1A1 (0.41) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL15999549 0.78 KDM4E (0.39) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL9027382 0.78 KDM4E (0.68) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL9168466 0.78 KDM4E (0.46) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL30390219 0.78 KDM4E (0.68) KDM4ELMNAMEN1KMT2ACYP1A2
SCHEMBL8094560 0.77 EPHA2 (0.53) KDM4ELMNAMEN1KMT2AALDH1A1
SCHEMBL10516924 0.76 LMNA (0.60) KDM4ELMNAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0266576-A2 1-Tert-alkyl-substituted naphthyridine and quinoline carboxylic acids as antibacterial agents Bristol-Myers Squibb Company (US) 1988-05-11 EP disclosed